Combination Chemotherapy in Treating Patients With Advanced Cancer of the Urothelium and Decreased Kidney Function

PHASE2CompletedINTERVENTIONAL
Timeline

Start Date

January 2, 2001

Primary Completion Date

February 28, 2003

Study Completion Date

June 15, 2007

Conditions
Bladder CancerTransitional Cell Cancer of the Renal Pelvis and UreterUrethral Cancer
Interventions
DRUG

gemcitabine hydrochloride

DRUG

paclitaxel

Trial Locations (16)

10461

Albert Einstein Clinical Cancer Center, The Bronx

14642

James P. Wilmot Cancer Center, Rochester

19104

University of Pennsylvania Cancer Center, Philadelphia

19111

Fox Chase Cancer Center, Philadelphia

44195

Cleveland Clinic Taussig Cancer Center, Cleveland

53295

Veterans Affairs Medical Center - Milwaukee (Zablocki), Milwaukee

54301

CCOP - St. Vincent Hospital Cancer Center, Green Bay, Green Bay

54449

CCOP - Marshfield Medical Research and Education Foundation, Marshfield

57104

CCOP - Sioux Community Cancer Consortium, Sioux Falls

58122

CCOP - Merit Care Hospital, Fargo

76508

CCOP - Scott and White Hospital, Temple

52403-1206

CCOP - Cedar Rapids Oncology Project, Cedar Rapids

49007-3731

CCOP - Kalamazoo, Kalamazoo

07019

Veterans Affairs Medical Center - East Orange, East Orange

44106-5065

Ireland Cancer Center, Cleveland

53226-3596

Medical College of Wisconsin, Milwaukee

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Eastern Cooperative Oncology Group

NETWORK

NCT00005644 - Combination Chemotherapy in Treating Patients With Advanced Cancer of the Urothelium and Decreased Kidney Function | Biotech Hunter | Biotech Hunter